期刊文献+

抗精神病药物对精神分裂症患者肝功能损害的临床观察 被引量:13

The clinical observation of schizophrenia patients' liver function injury caused by antipsychotic drugs
暂未订购
导出
摘要 目的:观察抗精神病药物引起精神分裂症患者的肝功能损害以及应用甘草酸二铵预防和治疗的可行性。方法:使用回顾性研究的方法,观察我院2001~2011年间住院的967例精神分裂症患者使用抗精神病药后引起肝功能损害的发生率以及使用甘草酸二铵(甘利欣)治疗肝功能损害的疗效,并使用卡方检验、logistic回归分析、t检验等方法来进行统计分析。结果:肝功能损害的发生率约为15.62%,肝功能异常的发生与连续服药的时间相关联,多在服药4周到6周左右,其中利培酮引起肝功能异常的发生率明显低于氯丙嗪,联合应用甘草酸二铵治疗,患者肝功能异常的发生率显著降低,且肝功能异常患者应用甘草酸二铵治疗后,大部分患者肝功能逐步恢复正常,疗效显著。结论:非经典抗精神病药物引起肝功能损害的发生率显著低于经典抗精神病药物,应用甘草酸二铵预防和治疗抗精神病药物所致肝功能损害有明确疗效。 Objective:To observe schizophrenia patients'liver injury caused by antipsychotic drugs and the feasibility of using Diammonium Glycyrrihizinate to prophylaxis and cure liver function injury. Methods :967 cases of schizophrenic patients from January 2001 to December 2011 in our hospital were retrospectively analyzed, using t test ,~2 test,logistic regression analysis to observe the rate of liver function injury caused by antipsychotic drugs and the curative effect of Diammonium Glycyrrihizinate. Results: The inci- dence of liver function injury was 15.62%, it~ associated with the continuous time that drugs taken; most of them took place in 4 -6 weeks after drugs taken. Obviously ,the rate of liver function injury caused by dispersal was much lower than chlorpromazine. The inci- dence of liver function injury was remarkably reduced by using Diammonium Glycyrrihizinate meanwhile, when patients find liver func- tion injury ,taking Diammonium Glycyrrihizinate orally, the liver function can bec6me normal gradually, the effect was remarkable. Conclusions: The incidence of liver function that induced by atypical antipsychotic drugs was less than induced by classical drugs. The curative effect of Diammonium Glycyrrihizinate to prophylaxis and treat liver function injury caused by antipsychotic drugs was conclu- sive.
出处 《中国民康医学》 2012年第23期2830-2832,共3页 Medical Journal of Chinese People’s Health
关键词 精神分裂症 肝功能损害 甘草酸二铵 利培酮 氯丙嗪 Schizophrenia Liver function injury Diammonium Glycyrrihizinate Risperdal Chlorpromazine
  • 相关文献

参考文献14

  • 1Lin Tsung - yi, Hung - ruing Chu, Hsien Rin, et al. Effects of social change on mental disorders in Taiwan: observations based on a 15 - year follow - up survey of general populations in three communities. Acta Psychiatr Scand,1999,348(Suppl) :11 -33.
  • 2Karno M, Norquist GS. Schizophrenia : epidemiology. In : Kaplan HI, Sadock BJ, eds. Comprehensive Textbook of Psychiatry. Wilkins: Baltimore,2005:902 -910.
  • 3Warner R,de Girolamo G. Schizophrenia. Geneva: World Health Organization ,2007:76 - 80,42 - 43.
  • 4中华医学会精神科分会.中国精神障碍分类与诊断标准(CC-MD-3)[M].第3版,济南:山东科学技术出版社,2001:28.
  • 5孙振晓,孟宪明,于相芬,吉立.抗精神病药物所致肝功能异常率及相关因素分析[J].四川精神卫生,2003,16(2):105-108. 被引量:16
  • 6高宏强,李佳翠.精神分裂症患者药物性肝损害的临床分析[J].中国医药导报,2010,7(16):42-43. 被引量:8
  • 7Takikawa H, Takamori Y, Kumagi T, et al. Assessment of 287Japanese cases of drug induced liver injury by the diagnostic scaleof the International Consensus Meeting [ J ]. Hepatol Res, 2003,273:192 - 195.
  • 8沈渔邮.精神病学[M].第4版.北京:人民卫生出版社,2003:462-486.
  • 9于欣,侯也之,舒良,王秀玲,李冰,刘卫红,林凯,杨顺才,宋丽华,廖安燕,谢家康,贾宏晓,张继志.利培酮治疗精神分裂症的开放性临床验证[J].中华精神科杂志,1997,30(2):79-82. 被引量:330
  • 10章华,刘忠纯,王高华.不同剂量利培酮治疗首发精神分裂症疗效及安全性的比较[J].中华精神科杂志,2004,37(1):26-29. 被引量:42

二级参考文献20

  • 1陈灏珠.实用内科学(第10版)[M].北京:人民卫生出版社,1997.1410-1413.
  • 2陈立成 白珍.氯氮平对肝功能的近期影响[J].中华神经精神科杂志,1991,24(5):281-281.
  • 3沈渔邨.精神病学[M].5版.北京:人民卫生出版社.2009:838.
  • 4Marder SR,Meibach RC.Risperidone in the treatment of schi-zophrenia[J].Am J Psychiatry,1994,151:825.
  • 5Livingston MG.Risperidone[J].Lancet,1994,343:457.
  • 6Szigeth E,Wiznitzer M,Branicky LA,et al.Risperidone-induced hepatotoxicity in children and adolescents?A chart review study[J].J Child Adolesc Psychopharmacol,1999,9:93-98.
  • 7于欣,侯也之,舒良,王秀玲,李冰,刘卫红,林凯,杨顺才,宋丽华,廖安燕,谢家康,贾宏晓,张继志.利培酮治疗精神分裂症的开放性临床验证[J].中华精神科杂志,1997,30(2):79-82. 被引量:330
  • 8舒良,中华神经精神科杂志,1987年,20卷,43页
  • 9Walker AM.Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal anti-inflammatory drugs.Arthritis Rheum,1997,40:201-208.
  • 10P. Karlsson,L. Farde,C. Halldin,G. Sedvall,L. Ynddal,M. Sloth-Nielsen. Oral administration of NNC 756 — a placebo controlled PET study of D1-dopamine receptor occupancy and pharmacodynamics in man[J] 1995,Psychopharmacology(1):1~8

共引文献452

同被引文献150

引证文献13

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部